Navigation Links
MedImmune Highlights Advances in Inflammatory Disease Pipeline With,Series of Data Presentations

anagement's current views and are based on certain assumptions about the success of this program. Actual results could differ materially from those currently anticipated as a result of a number of factors, including risks and uncertainties discussed in MedImmune's filings with the SEC. MedImmune is developing IL-9-related product candidates for potential future marketing. There can be no assurance that such development efforts will succeed, that such products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success.

Notice to Investors and Stockholders of MedImmune

This release is neither an offer to purchase nor a solicitation of an offer to sell shares of MedImmune. MedImmune stockholders are urged to read the relevant tender offer documents from AstraZeneca PLC that have been filed on May 3, 2007 because they contain important information that stockholders should consider before making any decision regarding tendering their shares. AstraZeneca has filed tender offer materials with the U.S. Securities and Exchange Commission, and MedImmune has also filed a Solicitation/Recommendation Statement on Schedule 14D-9 with respect to the offer. The tender offer materials (including an Offer to Purchase, a related Letter of Transmittal and certain other offer documents) and the Solicitation/Recommendation Statement contain important information, which should be read carefully before any decision is made with respect to the tender offer. The Offer to Purchase, the related Letter of Transmittal and certain other offer documents, as well as the Solicitation/Recommendation Statement, are available for free at the U.S. Securities and Exchange Commission's web site at http://www.sec.gov, at AstraZeneca's website at http://www.astrazeneca.com or at MedImmun
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
4. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
5. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
6. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
7. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
8. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
9. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
Post Your Comments:
(Date:3/30/2015)... 2015  Check-Cap Ltd. (NASDAQ: CHEK ), a ... of a preparation-free ingestible imaging capsule that utilizes low-dose ... its CEO, Guy Neev , will ring the ... Neev and Check-Cap will participate in the closing bell ... offering and simultaneous private placement which raised a total ...
(Date:3/30/2015)... 30, 2015  Building on the momentum of the first ... of medical alert systems, has announced aggressive plans to expand ... and Managed Care business models. The first quarter ... Tennessee and Louisiana ... contracts to span statewide coverage in each state. This brings ...
(Date:3/30/2015)... 2015 Research and Markets ... of the "Urological Catheters - Global ... offering. This report analyzes the ... Units and US$ Thousands by the following ... Peritoneal Catheters), and Urinary Catheters (Foley Catheters, ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7
... N.J., Oct. 20 A meta-analysis of clinical data ... for the European Association for the Study of Diabetes ... (insulin detemir [rDNA origin] injection) was not associated with ... to human insulin(1,2). , The analysis conducted by ...
... Oct. 20 Digirad Corporation (Nasdaq: DRAD ) announced ... make an investor presentation at the BIOCOM 4th Annual Investor ... conference will be held at the Hyatt Regency La Jolla ... with slides will include a discussion of Digirad,s business, strategic ...
Cached Medicine Technology:Data Analysis Reinforces the Safety Profile of Levemir(R) 2Data Analysis Reinforces the Safety Profile of Levemir(R) 3Data Analysis Reinforces the Safety Profile of Levemir(R) 4
(Date:3/31/2015)... 31, 2015 “ Prong ” was featured ... features the latest and coolest technology products available to consumers. ... conducted the review and shared with viewers how this phone ... Everyone knows that feeling when their phone is running out ... a new phone case that is a solution to this ...
(Date:3/31/2015)... With nationwide predictions of major floods due to ... pineapple express, the OPP is urging its insureds to ... , "Protecting Your Business" 09/23/2014, provides alarming statistics about ... business. , Here are 3 statistics that every business ... small businesses never reopen their doors after a flood ...
(Date:3/30/2015)... MA (PRWEB) March 31, 2015 ... mobility management services, has been announced as one of ... annual list the fastest-growing private companies in Massachusetts. ... the state’s fastest revenue growth from 2011 through 2014. ... the Boston Business Journal has recognized Wireless Analytics’s revenue ...
(Date:3/30/2015)... City, NY (PRWEB) March 31, 2015 ... Owner / Operator for Diamond Pharmacy Services, ... Ms. Mitchell is recognized with this prestigious distinction ... networking organization of professional women in the country, ... Association of Professional Women is a powerfully vibrant ...
(Date:3/30/2015)... 2015 The AAAHC, a private, ... the provision of high-quality health care through the ... and accreditation programs for 35 years. Through a ... to promote excellence in patient safety and care. ... and on-site evaluations by AAAHC expert surveyors, doctors, ...
Breaking Medicine News(10 mins):Health News:The Swiss Army Knife of Phone Cases was Featured on NewsWatch Television 2Health News:3 Statistics Every Business Owner Should Know About Flood Waters and Flood Insurance, from the Optometric Protector Plan® 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 2Health News:Wireless Analytics Growth Streak Continues; Named to Boston Business Journal’s Pacesetters Second Year In a Row 3Health News:National Association of Professional Women Announces Tamara Mitchell, Owner / Operator of Diamond Pharmacy Services, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2
... interests of pain patients in light of federal pain management ... American Academy of Pain Medicine (AAPM) will brief congress today ... , The crisis of under-treated pain extends well ... It is now a social issue with major economic and ...
... DATA ), a technology and services company focused ... reported its,operating results for the third quarter and first ... ended September 30, 2007, revenue decreased 52% to,$2,116,000, and ... $(0.26),per share on a basic and diluted basis. These ...
... CHICAGO, Nov. 8 Allscripts, the leading,provider of ... to improve healthcare, today announced results for the ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061005/ALLSCRIPTSLOGO-b ) Total revenue for ... $73.4,million, a record for the company, compared to ...
... Develop Rapid Molecular ... -, SAN DIEGO, Nov. 8 Gen-Probe (Nasdaq: ... no longer intends to,fund the companies, collaboration to develop rapid ... formally terminate the,collaboration in the coming days. "Gen-Probe continues ...
... Revenue Growth, Expanding Installed Base and ... Data Around the Use of IVUS, SAN DIEGO, Nov. ... of intravascular ultrasound (IVUS) and,functional measurement (FM) products designed to ... today reported results,for the third quarter and first nine months ...
... ... Biologics to Biotest, BOCA RATON, Fla., Nov. 8 ... results. The company recorded a net loss of $15.9 million, or,$0.26 ... million, or $0.12 per share, of expenses for unusual items described,below. ...
Cached Medicine News:Health News:National physician organization supports Capps-Rogers Bill at today's congressional briefing 2Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 2Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 3Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 4Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 5Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 6Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 7Health News:DATATRAK International, Inc. Announces 2007 Third Quarter and Nine Month Operating Results 8Health News:Allscripts Reports Third Quarter 2007 Results 2Health News:Allscripts Reports Third Quarter 2007 Results 3Health News:Allscripts Reports Third Quarter 2007 Results 4Health News:Allscripts Reports Third Quarter 2007 Results 5Health News:Allscripts Reports Third Quarter 2007 Results 6Health News:Allscripts Reports Third Quarter 2007 Results 7Health News:Allscripts Reports Third Quarter 2007 Results 8Health News:Allscripts Reports Third Quarter 2007 Results 9Health News:Allscripts Reports Third Quarter 2007 Results 10Health News:Allscripts Reports Third Quarter 2007 Results 11Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 2Health News:3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration 3Health News:Volcano Reports Record Third Quarter Revenues 2Health News:Volcano Reports Record Third Quarter Revenues 3Health News:Volcano Reports Record Third Quarter Revenues 4Health News:Volcano Reports Record Third Quarter Revenues 5Health News:Volcano Reports Record Third Quarter Revenues 6Health News:Volcano Reports Record Third Quarter Revenues 7Health News:Volcano Reports Record Third Quarter Revenues 8Health News:Volcano Reports Record Third Quarter Revenues 9Health News:Volcano Reports Record Third Quarter Revenues 10Health News:Volcano Reports Record Third Quarter Revenues 11Health News:Volcano Reports Record Third Quarter Revenues 12Health News:Volcano Reports Record Third Quarter Revenues 13Health News:Volcano Reports Record Third Quarter Revenues 14Health News:Volcano Reports Record Third Quarter Revenues 15Health News:Nabi Biopharmaceuticals Announces Third Quarter 2007 Financial Results and Positive Vote from November 8, 2007 Special Stockholders Meeting 2
This set is designed to introduce the low vision practitioner to the Keeler telescopic system....
... Featuring up to 20 ... examination in the vertical, ... plus the option to ... corneal transillumination., ,Filters include ...
Comes complete in its own carrying case. There are 24 lenses, 13mm diameter -6D to +6D in 0.5D steps. Mounted in tough, yet light alloy frame....
... Interventions, like all important missions, ... guide you to your destination. ... you this dependability. So you ... the intervention and not have ...
Medicine Products: